Robotic versus laparoscopic gastrectomy for gastric cancer: A meta-analysis of short outcomes

Xiong, Bin; Ma, L i; Cai-quan, Zhang

doi:10.1016/j.suronc.2012.05.004

Cited by 78 publications

(90 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…11,64,[69][70][71] In comparative studies among OG, LG, and RAG, some authors 63,72 have reported that the estimated blood loss in the robotic group was significantly lower than in the open and laparoscopic groups. Similar results were confirmed in the meta-analysis from Xiong et al, 61 whose data appear to confirm the ability of surgeons to better control bleeding when using the robotic system, compared to conventional laparoscopy.…”

supporting

confidence: 71%

“…68 The LOS was shorter in patients undergoing RAG than in those having LG, but this difference was not found to be statistically significant in two meta-analyses. 59,61 However, the hospital stay for RAG was significantly shorter than that for OG and was consistent in all series. 59 The mean operating time is commonly longer in RS than in conventional laparoscopy or open surgery.…”

supporting

confidence: 56%

“…56,57 The first experiences of robot-assisted gastrectomy (RAG) were published almost 10 years ago, 11,58 and more recent papers reported no appreciable differences between patients who had RAG and LG in terms of surgical complications, mortality, conversion rate, LOS, and oncological adequacy. 59,60 However, only very few meticulous studies have been published on RAG, and a recent meta-analysis 61 selected only three RCTs comparing robotic surgery and laparoscopy. No significant differences in terms of complications, mortality, conversion, LOS, and number of nodes retrieved were detected between the two groups.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Gastrointestinal robotic surgery: challenges and developments

Becchini¹,

Annecchiarico²,

Marino³

et al. 2015

RSRR

View full text Add to dashboard Cite

Abstract:The rapid diffusion of new technologies in surgery, together with high expectations of both patients and the mass media, has led to many gastrointestinal procedures being approached using robots. Robotic technology seems to resolve many of the drawbacks of laparoscopic advanced procedures, such as anastomotic reconstructions, accurate lymphadenectomy, and vascular sutures. In addition, a deeper tridimensional steady vision with excellent high definition, the EndoWrist technology offering seven degrees of freedom, tremor filtration, scaled motion, optimal working ergonomics, and avoidance of the 'fulcrum effect', are the main strengths of the da Vinci ® system. The use of near-infrared technology and the possibility of tutoring through a double-console will most likely add many more advantages of this technology over laparoscopy alone. However, none of the gastrointestinal robotic interventions has reached a level of evidence-based efficacy that enables it to be routinely applied. The main limitations of robotic gastrointestinal procedures are represented by the learning curve, the higher costs of robotic surgery compared to traditional and laparoscopic surgery, and the longer operation times, including setup and organizational troubles. Moreover, while the limits of robotics for benign diseases are mainly represented by technical issues, oncologic outcomes remain the foundation of any procedures to cure malignancies, and long-term follow-up is still lacking. On the other hand, a word of caution should be presented on the adoption of robotics in too many surgical units without the correct and formal technical background and third-party control to guarantee the best outcomes for patients at minimum risk. Therefore, the robotic treatment of gastrointestinal diseases requires a thorough analysis of the published evidence, in order to determine the correct indications and patient selection. This review aims to examine the evidence for the use of robotic surgery in both malignancies and benign disease arising from the gastrointestinal area. Future developments in robotics and ongoing areas of research are also analyzed.

show abstract

supporting

confidence: 71%

supporting

confidence: 56%

mentioning

confidence: 99%

See 1 more Smart Citation

Gastrointestinal robotic surgery: challenges and developments

Becchini¹,

Annecchiarico²,

Marino³

et al. 2015

RSRR

View full text Add to dashboard Cite

show abstract

“…The quality of included studies was estimated according to the Newcastle-Ottawa Scale (http://www. ohri.ca/programs/clinical_epidemiology/oxford.asp) and a previously published meta-analysis (Xiong et al, 2012).…”

Section: Data Extraction and Quality Assessmentmentioning

confidence: 99%

Meta-analysis of Outcomes Compared between Robotic and Laparoscopic Gastrectomy for Gastric Cancer

Liao

Xie²,

Li³

et al. 2013

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

“…In addition, meta-analysis results revealed that use of robotic surgery for gastric cancer significantly decreases intraoperative blood loss. Also, comparable morbidity and mortality to laparoscopic surgery was reported (41). However, longer operation time and higher cost are the limitations of clinical application of robotic surgery in gastric cancer in spite of technical superiority over laparoscopic surgery such as 3-dimensional imaging, surgical instrument with a high degree of angulation and filtration of resting tremor.…”

Section: Robotic Surgery For Gastric Cancermentioning

confidence: 87%

Ongoing surgical clinical trials on minimally invasive surgery for gastric cancer: Korea

Lee

2016

Transl. Gastroenterol. Hepatol.

View full text Add to dashboard Cite

Robotic versus laparoscopic gastrectomy for gastric cancer: A meta-analysis of short outcomes

Cited by 78 publications

References 36 publications

Gastrointestinal robotic surgery: challenges and developments

Gastrointestinal robotic surgery: challenges and developments

Meta-analysis of Outcomes Compared between Robotic and Laparoscopic Gastrectomy for Gastric Cancer

Ongoing surgical clinical trials on minimally invasive surgery for gastric cancer: Korea

Contact Info

Product

Resources

About